GM1 gangliosidosis

Views & Analysis

Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner.

News

The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.